home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Scholar Rock Holding Corporation - Common Stock (NQ:SRRK)

50.90 -2.02 (-3.82%)

Streaming Delayed Price Updated: 2:56 PM EDT, Aug 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Scholar Rock Holding Corporation - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 15, 2023

From Scholar Rock

Via Business Wire

Why JAKKS Pacific Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 10, 2023

Gainers Barnes & Noble Education, Inc. (NYSE: BNED) jumped 39% to $2.39 after the company posted better-than-expected quarterly sales.

Via Benzinga

Scholar Rock Reports Full Year 2022 Financial Results and Highlights Business Progress

March 07, 2023

From Scholar Rock

Via Business Wire

US Stocks Could Consolidate As S&P 500, Nasdaq Futures Tick Up Ahead Of Fed Chair Powell's Congressional Testimony ↗

March 06, 2023

Stocks could pause on Monday after returning to winning ways in the past week, as the focus shifts to Fed Chair Jerome Powell’s two-day Congressional testimony this week. Cues From Last Week’s...

Via Benzinga

Scholar Rock to Present 24-Month Data from the Phase 2 TOPAZ trial at the 2023 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference

March 01, 2023

From Scholar Rock

Via Business Wire

Scholar Rock to Present at the Cowen 43rd Annual Health Care Conference

February 27, 2023

From Scholar Rock

Via Business Wire

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 17, 2023

From Scholar Rock

Via Business Wire

Scholar Rock Appoints Tracey M. Sacco as Chief Commercial Officer

February 06, 2023

From Scholar Rock

Via Business Wire

Here's What's Next For Biohaven After Its $12 Billion Pfizer Buyout, According To CEO Vlad Coric ↗

February 02, 2023

The company that remains still has a large pipeline of non-migraine assets.

Via Investor's Business Daily

Goldman Sachs, New Oriental Education & Technology And Other Big Stocks Moving Lower On Tuesday ↗

January 17, 2023

U.S. stocks traded lower, with the Dow Jones dropping around 300 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

TSMC, CommScope Holding And Other Big Stocks Moving Higher On Thursday ↗

January 12, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Insiders Buying Heska, B. Riley Financial And 2 Other Stocks ↗

January 10, 2023

Although US stocks closed mixed on Monday, there were a few notable insider trades.

Via Benzinga

Scholar Rock Provides Corporate Update and Highlights Priorities for 2023

January 09, 2023

From Scholar Rock

Via Business Wire

Scholar Rock to Present at the 41st Annual J.P. Morgan Healthcare Conference

January 03, 2023

From Scholar Rock

Via Business Wire

Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session ↗

December 30, 2022

Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the...

Via Benzinga

Salesforce To $225? Plus Mizuho Predicts $135 For VMware ↗

November 15, 2022

Mizuho cut the price target on Salesforce, Inc. (NYSE: CRM) from $235 to $225. Mizuho analyst Gregg Moskowitz maintained the stock with a Buy rating. Salesforce shares rose 0.9% to $160.06 in...

Via Benzinga

Scholar Rock Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

November 15, 2022

From Scholar Rock

Via Business Wire

Scholar Rock Reports Third Quarter 2022 Financial Results and Highlights Business Progress

November 14, 2022

From Scholar Rock

Via Business Wire

Recent Phase 1 DRAGON Data Show SRK-181 Continues to be Well Tolerated with Early Indications of Efficacy

November 10, 2022

From Scholar Rock

Via Business Wire

Scholar Rock Appoints Jing L. Marantz, M.D., Ph.D., M.B.A., as Chief Medical Officer

November 09, 2022

From Scholar Rock

Via Business Wire

Scholar Rock to Participate in Upcoming Investor Conferences

November 08, 2022

From Scholar Rock

Via Business Wire

Why Pinterest Shares Jumped Around 14%; Here Are 69 Biggest Movers From Friday ↗

October 31, 2022

Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) jumped 153.9% to close at $3.30 on Friday.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 28, 2022

Gainers

Via Benzinga

Apple, Intel, And Some Other Big Stocks Moving Higher On Friday ↗

October 28, 2022

U.S. stocks traded higher, with the Dow Jones gaining more than 500 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Over $1 Million Bet On Scholar Rock Holding? 3 Stocks Insiders Are Buying ↗

October 28, 2022

Although US stocks closed mixed on Thursday, there were a few notable insider trades.

Via Benzinga

New Phase 2 TOPAZ Trial Data Indicate Positive Trends in Quality-of-Life Measures Over 24 Months with Apitegromab for Nonambulatory Patients with Types 2 and 3 SMA

October 22, 2022

From Scholar Rock

Via Business Wire

Scholar Rock to Present Data from the Phase 1 DRAGON trial at the SITC 37th Annual Meeting

October 06, 2022

From Scholar Rock

Via Business Wire

Scholar Rock to Present New 24-Month Data from Phase 2 TOPAZ Study at Two International Conferences: World Muscle Society Congress and International Scientific Congress on Spinal Muscular Atrophy

October 04, 2022

From Scholar Rock

Via Business Wire

Scholar Rock Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

September 22, 2022

From Scholar Rock

Via Business Wire

Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday ↗

September 23, 2022

Gainers

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com